Clinical Trial Update: Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating genetic changes in non-small cell lung cancer patients treated with vinorelbine and gemcitabine before surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED